$5.50
+
$0.10 (1.85%)
End-of-day quote: 01/12/2023
NasdaqGM:CVAC
CureVac N.V. Annual Report
| Year | Year | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$67.42M | $102.99M | $48.87M | $17.42M |
| Rev. | Revenue |
|
$67.42M | $102.99M | $48.87M | $17.42M |
| GM % | Gross Margin % |
|
-135.79% | -109.02% | 71.10% | -59.72% |
| OI | Operating Income |
|
$-226.34M | $-1030.35M | $-133.55M | $-104.88M |
| OM | Operating Margin |
|
0.00% | 0.00% | -273.27% | 0.00% |
| NI | Net Income |
|
$-249.03M | $-411.72M | $-129.12M | $-99.87M |
| EPS | Earnings Per Share |
|
$-1.32 | $-4.18 | $-0.98 | $-1.03 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 |
| Sha. | Shares |
|
194.95m | 187.12m | 180.46m | 96.69m |
| OCF | Operating Cash Flow |
|
$-286.18M | $-733.13M | $522.40M | $-86.96M |
| CS | Cap Spending |
|
$-36.33M | $-124.22M | $-36.33M | $-11.17M |
| FCF | Free Cash Flow |
|
$-322.51M | $-857.35M | $486.07M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-2.01 | $-4.63 | $3.59 | $-1.03 |
